BioCentury | Feb 6, 2021
Product Development

AstraZeneca’s vaccine results suggest a modality-independent dip in protection against variants

...second study is a Phase I/II vaccine combination trial of AZD1222 and Sputnik V from N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...AZD1222, ChAdOx1 nCoV-19) Comirnaty, Pfizer-BioNTech COVID-19 Vaccine (PF-07302048, BNT162, BNT162b2) Sputnik V (Gam-COVID-Vac) AstraZeneca plc University of Oxford Pfizer Inc. BioNTech SE N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology covid19 covid-19 cov19sci cov19count chs2020 bee2021 cov19sci cov19count...
BioCentury | Feb 4, 2021
Product Development

Vaxart falls on mixed Phase I readout for COVID-19 vaccine; plus BMS-Rockefeller mAb cocktail deal and vaccine updates for Sputnik V, Novavax, Bharat-Ocugen and Sinovac

...in January. Sandi Wong Oral tablet COVID-19 vaccine (VXA-CoV2-1) Gam-COVID-Vac Lyo NVX-CoV2373 Covaxin (BBV152) CoronaVac, PiCoVacc Vaxart Inc. Bristol Myers Squibb Co. The Rockefeller University N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology Novavax...
BioCentury | Feb 3, 2021
Product Development

Sputnik V on par with other COVID-19 vaccines before and after boost

...the elderly.The vaccine’s efficacy of 91.6% in the full population was reported in December by N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...low-cost manufacturing process and its storage temperate of 2-8°C to engage in vaccine diplomacy. Sandi Wong Gam-COVID-Vac Lyo N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology covid19 covid-19 cov19sci cov19count chs2020 bee2021 cov19sci cov19count...
BioCentury | Jan 30, 2021
Product Development

J&J adds to emerging patchwork of COVID variant data, positions single-dose vaccine as bulwark against severe disease

...reported for vaccines from Moderna Inc. (NASDAQ:MRNA), partners Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) and N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
BioCentury | Jan 13, 2021
Product Development

mRNA vaccines still lead the COVID-19 pack: Data Byte

...NASDAQ:BNTX) has come close to matching their efficacy: the Russian viral vector vaccine Sputnik V from N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology.A...
BioCentury | Dec 15, 2020
Product Development

Dec. 14 COVID roundup: Phase III miss for Incyte-Novartis JAK inhibitor; Queensland vaccine program axed; plus Sputnik V final efficacy and Phase II starts for CureVac and Inovio

...tests.”Sputnik V yields 91% efficacy at final planned analysisThe Russian Direct Investment Fund and the N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...#), INC424 (Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) Gam-COVID-Vac Lyo CVnCoV INO-4800 Novartis AG Incyte Corp. University of Queensland CSL Ltd. N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology CureVac...
BioCentury | Dec 12, 2020
Product Development

Dec. 11 Quick Takes: AZ to run combo trial with Sputnik; plus Phase III hits for Lilly, AbbVie and TG, data from Immutep, NVS, Mycovia, Sarepta and Greenwich

...the adenovirus serotype 26 (Ad26) component of Sputnik V from the Direct Investment Fund and N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...growth factor receptor 2JAK-1 – Janus kinase-1 LAG3 (CD223) – Lymphocyte-activation gene 3 BC Staff AZD1222 (ChAdOx1 nCoV-19) Gam-COVID-Vac Lyo N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology AstraZeneca...
BioCentury | Nov 12, 2020
Product Development

Russian vaccine data add to expectations for COVID-19 vaccine efficacy set by BioNTech, Pfizer; Moderna readout coming

...SPARK Global developing nasal drops for temporary immunity. N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...markets as early as year-end. Sandi Wong PF-07302048 (BNT162) Stanford University N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology Pfizer...
BioCentury | Sep 23, 2020
Deals

Sept. 22 Quick Takes: Celgene CVR still in play; plus Dr. Reddy’s in Sputnik deal, $30M for Siolta, Amgen-Lilly, BioNTech-Novartis, Genentech-Scenic

...timing of clinical trials and a regulatory decision. Developed by the Russian Ministry of Health’s N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
BioCentury | Sep 9, 2020
Product Development

International group of researchers call Russian COVID-19 vaccine data into question

...spike and each delivered once in separate immunizations.N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...and prime-boost regimens of their vaccines. Sandi Wong Gam-COVID-Vac Lyo Gam-COVID-Vac N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology SARS-CoV-2...
Items per page:
1 - 10 of 13
BioCentury | Feb 6, 2021
Product Development

AstraZeneca’s vaccine results suggest a modality-independent dip in protection against variants

...second study is a Phase I/II vaccine combination trial of AZD1222 and Sputnik V from N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...AZD1222, ChAdOx1 nCoV-19) Comirnaty, Pfizer-BioNTech COVID-19 Vaccine (PF-07302048, BNT162, BNT162b2) Sputnik V (Gam-COVID-Vac) AstraZeneca plc University of Oxford Pfizer Inc. BioNTech SE N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology covid19 covid-19 cov19sci cov19count chs2020 bee2021 cov19sci cov19count...
BioCentury | Feb 4, 2021
Product Development

Vaxart falls on mixed Phase I readout for COVID-19 vaccine; plus BMS-Rockefeller mAb cocktail deal and vaccine updates for Sputnik V, Novavax, Bharat-Ocugen and Sinovac

...in January. Sandi Wong Oral tablet COVID-19 vaccine (VXA-CoV2-1) Gam-COVID-Vac Lyo NVX-CoV2373 Covaxin (BBV152) CoronaVac, PiCoVacc Vaxart Inc. Bristol Myers Squibb Co. The Rockefeller University N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology Novavax...
BioCentury | Feb 3, 2021
Product Development

Sputnik V on par with other COVID-19 vaccines before and after boost

...the elderly.The vaccine’s efficacy of 91.6% in the full population was reported in December by N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...low-cost manufacturing process and its storage temperate of 2-8°C to engage in vaccine diplomacy. Sandi Wong Gam-COVID-Vac Lyo N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology covid19 covid-19 cov19sci cov19count chs2020 bee2021 cov19sci cov19count...
BioCentury | Jan 30, 2021
Product Development

J&J adds to emerging patchwork of COVID variant data, positions single-dose vaccine as bulwark against severe disease

...reported for vaccines from Moderna Inc. (NASDAQ:MRNA), partners Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) and N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
BioCentury | Jan 13, 2021
Product Development

mRNA vaccines still lead the COVID-19 pack: Data Byte

...NASDAQ:BNTX) has come close to matching their efficacy: the Russian viral vector vaccine Sputnik V from N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology.A...
BioCentury | Dec 15, 2020
Product Development

Dec. 14 COVID roundup: Phase III miss for Incyte-Novartis JAK inhibitor; Queensland vaccine program axed; plus Sputnik V final efficacy and Phase II starts for CureVac and Inovio

...tests.”Sputnik V yields 91% efficacy at final planned analysisThe Russian Direct Investment Fund and the N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...#), INC424 (Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) Gam-COVID-Vac Lyo CVnCoV INO-4800 Novartis AG Incyte Corp. University of Queensland CSL Ltd. N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology CureVac...
BioCentury | Dec 12, 2020
Product Development

Dec. 11 Quick Takes: AZ to run combo trial with Sputnik; plus Phase III hits for Lilly, AbbVie and TG, data from Immutep, NVS, Mycovia, Sarepta and Greenwich

...the adenovirus serotype 26 (Ad26) component of Sputnik V from the Direct Investment Fund and N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...growth factor receptor 2JAK-1 – Janus kinase-1 LAG3 (CD223) – Lymphocyte-activation gene 3 BC Staff AZD1222 (ChAdOx1 nCoV-19) Gam-COVID-Vac Lyo N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology AstraZeneca...
BioCentury | Nov 12, 2020
Product Development

Russian vaccine data add to expectations for COVID-19 vaccine efficacy set by BioNTech, Pfizer; Moderna readout coming

...SPARK Global developing nasal drops for temporary immunity. N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...markets as early as year-end. Sandi Wong PF-07302048 (BNT162) Stanford University N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology Pfizer...
BioCentury | Sep 23, 2020
Deals

Sept. 22 Quick Takes: Celgene CVR still in play; plus Dr. Reddy’s in Sputnik deal, $30M for Siolta, Amgen-Lilly, BioNTech-Novartis, Genentech-Scenic

...timing of clinical trials and a regulatory decision. Developed by the Russian Ministry of Health’s N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
BioCentury | Sep 9, 2020
Product Development

International group of researchers call Russian COVID-19 vaccine data into question

...spike and each delivered once in separate immunizations.N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology...
...and prime-boost regimens of their vaccines. Sandi Wong Gam-COVID-Vac Lyo Gam-COVID-Vac N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology SARS-CoV-2...
Items per page:
1 - 10 of 13